Efficacy and safety of eplivanserin 5mg / day on sleep maintenance insomnia: A 12 week multicentre randomised double blind placebo controlled study following by an open treatment phase extension

  • Krum, Henry (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/06 → 31/12/07